GlassScriptPhysician profile
Darshan Saluja
NPI 1164498523
$6,839.42
in general payments reported to CMS, 2019-2025
35 companies · $1,326 in 2025
The $1,326 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $84.63 · 2021: $838 · 2022: $807 · 2023: $1,930 · 2024: $1,625 · 2025: $1,326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,881.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,209.52 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $1,013.88 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Dexcom, INC. | $606.48 | 2024-2025 | Dexcom G6 Transmitter, Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Novo Nordisk INC | $553.27 | 2019-2025 | Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $533.54 | 2020-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $389.88 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $325.31 | 2023-2025 | Gemtesa |
| Astellas Pharma US INC | $247.62 | 2019-2021 | |
| Lilly USA, LLC | $246.21 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $222.32 | 2021-2025 | Freestyle Libre 3 |
| Horizon Therapeutics Plc | $222.03 | 2023 | Krystexxa |
| Abbvie INC. | $171.17 | 2021-2025 | Creon, Linzess, Viberzi |
| Exact Sciences Corporation | $167.45 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $144.17 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.79 | 2022-2023 | Jardiance |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $84.20 | 2022-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Becton, Dickinson and Company | $69.82 | 2022-2025 | Venclose Maven Catheter |
| Neurocrine Biosciences, INC. | $64.01 | 2024 | Ingrezza |
| E.R. Squibb & Sons, L.L.C. | $45.07 | 2023 | Eliquis |
| Novartis Pharmaceuticals Corporation | $39.76 | 2019-2022 | |
| Smith+Nephew, INC. | $37.22 | 2022-2025 | Collagenase Santyl |
| Amgen INC. | $35.18 | 2021-2025 | Krystexxa |
| Embecta Corp. | $34.94 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Sanofi Pasteur INC. | $31.17 | 2025 | |
| Gilead Sciences, INC. | $29.76 | 2025 | |
| Seqirus USA INC | $29.22 | 2019 | |
| Medtronic, INC. | $27.12 | 2022 | |
| Tactile Systems Technology INC | $22.72 | 2019 | |
| Watermark Medical, INC. | $20.80 | 2024 | |
| Nevro Corp. | $20.28 | 2024 | Senza |
| Janssen Pharmaceuticals, INC | $20.13 | 2024 | Xarelto |
| Esperion Therapeutics, INC. | $18.57 | 2025 | Nexletol |
| Kowa Pharmaceuticals America, INC. | $18.55 | 2025 | Zoryve |
| Teva Pharmaceuticals USA, INC. | $16.02 | 2022 | |
| Nestle Healthcare Nutrition INC. | $12.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darshan Saluja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.